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Abstract
Background: There is emerging evidence that background exposure to persistent organic pollutants (POPs) are important
in the development of conditions predisposing to diabetes as well as of type 2 diabetes itself. We recently reported that low
dose POPs predicted incident type 2 diabetes in a nested case-control study. The current study examined if low dose POPs
predicted future adiposity, dyslipidemia, and insulin resistance among controls without diabetes in that study.
Methodology/Principal Findings: The 90 controls were diabetes-free during 20 years follow-up. They were a stratified
random sample, enriched with overweight and obese persons. POPs measured in 1987-88 (year 2) sera included 8
organochlorine (OC) pesticides, 22 polychlorinated biphenyls (PCBs), and 1 polybrominated biphenyl (PBB). Body mass
index (BMI), triglycerides, HDL-cholesterol, LDL-cholesterol, and homeostasis model assessment value for insulin resistance
(HOMA–IR) were study outcomes at 2005-06 (year 20). The evolution of study outcomes during 18 years by categories of
serum concentrations of POPs at year 2 was evaluated by adjusting for the baseline values of outcomes plus potential
confounders. Parallel to prediction of type 2 diabetes, many statistically significant associations of POPs with dysmetabolic
conditions appeared at low dose, forming inverted U-shaped dose-response relations. Among OC pesticides, p,p’-DDE most
consistently predicted higher BMI, triglycerides, and HOMA-IR and lower HDL-cholesterol at year 20 after adjusting for
baseline values. Oxychlordane, trans-nonachlor, and hexachlorobenzene also significantly predicted higher triglycerides.
Persistent PCBs with $7 chlorides predicted higher BMI, triglycerides, and HOMA-IR and lower HDL-cholesterol at year 20
with similar dose-response curves.
Conclusions/Significance: Simultaneous exposure to various POPs in the general population may contribute to
development of obesity, dyslipidemia, and insulin resistance, common precursors of type 2 diabetes and cardiovascular
diseases. Although obesity is a primary cause of these metabolic abnormalities, POPs exposure may contribute to excess
adiposity and other features of dysmetabolism.
Citation: Lee D-H, Steffes MW, Sjo ¨din A, Jones RS, Needham LL, et al. (2011) Low Dose Organochlorine Pesticides and Polychlorinated Biphenyls Predict Obesity,
Dyslipidemia, and Insulin Resistance among People Free of Diabetes. PLoS ONE 6(1): e15977. doi:10.1371/journal.pone.0015977
Editor: Xiaoping Pan, East Carolina University, United States
Received September 20, 2010; Accepted December 1, 2010; Published January 26, 2011
Copyright:  2011 Lee et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Supported by National Heart, Lung, and Blood Institute contracts N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050 (CARDIA field centers),
N01-HC-95095 (CARDIA Coordinating Center), and grant R01-HL-53560 (YALTA). The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jacob004@umn.edu
{Deceased.
Introduction
There is emerging evidence that background exposure to
persistent organic pollutants (POPs) may play an important role in
the development of type 2 diabetes. Recently, we reported that
serum concentrations of some POPs, in particular organochlorine
(OC) pesticides and polychlorinated biphenyls (PCBs), predicted
incident type 2 diabetes 1in a nested case-control study[1],
concordant with cross-sectional findings in the U.S. general
population[2], [3]. Among OC pesticides, Chlordane compounds
were most strongly associated with type 2 diabetes while among
PCBs, persistent congeners mainly predicted type 2 diabetes.
Importantly, POPs at low doses, similar to current population
exposure levels, increased the risk of diabetes while higher dose
POPs did not increase the risk[1], similar to known low dose
effects of endocrine disruptors[4], [5]. Incident type 2 diabetes was
also associated with p,p’-DDE, but not PCBs, in 471 Great Lakes
Sport Fish Consumers[6].
In the current paradigm for type 2 diabetes, obesity results from
energy imbalance, insulin resistance from obesity, and exhaustion
of pancreatic beta cells from overproduction of insulin to
compensate for insulin resistance, which ultimately progresses to
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e15977diabetes[7]. In fact, background exposure to OC pesticides and
PCBs was cross-sectionally associated with insulin resistance and
dyslipidemia even among people without diabetes[8], [9]. Also,
p,p’-DDE exposure in utero was linked to obesity in adult female
offspring of the Michigan fisheater cohort[10]. Together, these
findings suggest that low dose OC pesticides and PCBs may play a
role in dysmetabolism and diabetogenesis even in its developmen-
tal stages.
One recent animal study strongly supported this concept. Rats
exposed to POPs through the consumption of fish oil contaminated
withvariousPOPsdevelopedabdominalobesity,hepatosteatosis,and
insulin resistance[11]. Also, POPs down-regulated insulin-induced
gene-1andLpin1,twomasterregulatorsoflipidhomeostasis[11].We
know of no previous prospective study of whether human exposure to
POPs predicts obesity, insulin resistance, and associated metabolic
disorders. Therefore, we examined the relationship of serum
concentrations of POPs with adiposity, dyslipidemia, and insulin
resistanceamong peopleconfirmed to be diabetes-free on 5 occasions
over 20 years, using the control group of our nested case-control
study[1]. Based on previous findings, we hypothesized stronger
dysmetabolic effects at low dose POPs.
Methods
Source population
CARDIA focuses on cardiovascular disease risk development in
participants initially aged 18 to 30 years. In brief, 5,115 African
American and white participants were recruited at baseline in
1985–1986 (year 0)[12] and follow-up examinations were
completed at years 2, 5, 7, 10, 15, and 20 (2005-06) in 91%,
86%, 81%, 79%, 74%, and 72% respectively, of survivors.
The study was approved by the University of Minnesota
Institutional Review Board, as well as institutional review boards
at the Universities of Alabama at Birmingham, Northwestern
University, and the Division of Research at Kaiser Permanente
Health Care Plan. Written informed consent was obtained at
every examination. Participants in this study were 90 controls
selected from those who had fasting glucose ,100 mg/dL at all 5
examinations (years 0, 7, 10, 15, and 20) at which glucose was
measured. Controls were selected at random from each of several
year 0 body mass index (BMI) categories (,20, 20–24.9, 25–29.9,
30–39.9, and 40+ kg/m2); these categories were chosen so that
controls were frequency matched to cases.
Measurement
Demographics, health behaviors, anthropometrics, and various
clinical variables were measured at baseline and follow-up
examinations. Blood samples were collected after an overnight
fast. BMI was measured weight/height
2 (kg/m
2). Plasma total
cholesterol, high-density lipoprotein cholesterol (HDL-C), and
triglycerides were determined enzymatically by Northwest Lipids
Research Laboratory (Seattle, Washington). Low-density lipopro-
tein cholesterol (LDL-C) was computed using the Friedewald
equation. Fasting plasma glucose was determined using the
hexokinase-ultraviolet method and fasting plasma insulin by
radioimmunoassay (both at Linco Research Inc., St Louis,
Missouri, USA). The homeostasis model assessment value for
insulin resistance (HOMA–IR) was calculated as (glucose in
mmol/L 6insulin in mIU/mL)/22.5.
POPs analyses
POPs were measured in stored 2 mL serum samples collected at
year 2 (stored frozen at 270uC until analysis). The samples were
analyzed by solid phase extraction and final determination using
gas chromatography isotope dilution high-resolution mass spec-
trometry (GC/ID-HRMS) at the Centers for Disease Control and
Prevention[13]. Laboratory personnel were masked to all
CARDIA data, including case-control status. A total of 55 POPs
were measured: 9 organochlorine (OC) pesticides, 35 polychlori-
nated biphenyl (PCB) congeners, 10 polybrominated diphenyl
ether (PBDE) congeners, and 1 polybrominated biphenyl (PBB)
congener (Table S1).
Statistical methods
Lipid standardized concentrations, the concentration of serum
POP value divided by total serum lipid content (mg/dL), have
generally been reported in epidemiological studies, since POPs are
predominantly carried in the lipid component of the blood.
However, according to a simulation study[14], wet weight
concentrations adjusting for triglycerides and total cholesterol
had less bias than did lipid standardized concentrations. Thus, we
presented wet weight concentrations adjusting for triglycerides and
total cholesterol by including these two lipid profiles into the
models as covariates. On the other hand, as POPs themselves can
disturb lipid metabolism[9], [15], adjustment for serum lipid
concentrations may represent over-adjustment. Even though not
adjusting for triglycerides and total cholesterol led to stronger
associations, we presented adjusted results as a conservative
analysis. Furthermore adjustment for baseline values is needed so
that the year 20 outcome value represents the evolution of the
study outcomes over 18 years. Analyses were done across quartiles
of individual POPs, with sample sizes in each quartile of each
individual POP provided in Table S2. Only measurements with
more than 75% of values above the detection limit (31 POPs: 8
OC pesticides, 22 PCBs, and 1 PBB congeners) were included,
placing participants with non-detectable concentrations in the
lowest quartile of each POP.
We used general linear models to explore the associations of
serum concentrations of POPs at year 2 with BMI, triglycerides,
HDL-cholesterol, LDL-cholesterol, and HOMA-IR at the year 20
examination. The covariates included age, sex, race, triglycerides
and total cholesterol at year 2. Year 20 HDL-cholesterol and
HOMA-IR were additionally adjusted for their baseline values at
year 2 and year 7, respectively. We considered P,0.05 as
statistically significant, but, considering the small sample size, we
also comment on results with Ptrend or Pquadratic,0.10.
Table 1. Baseline characteristics of study subjects.
Characteristics
Age (years) 27.263.3
Men, % 31.1
White, % 51.1
BMI (kg/m
2) 29.166.7
Triglycerides (mg/dL) 78.4646.4
HDL-cholesterol (mg/dL) 53.2613.7
LDL-cholesterol (mg/dL) 111.5632.9
Fasting glucose
* (mg/dL) 87.566.5
Fasting insulin
* (mIU/mL) 12.966.9
HOMA-IR
* (mmol/L * mIU/mL) 3.161.7
*Baseline was CARDIA year 2, except for fasting glucose, fasting insulin, and
HOMA-IR, which were measured at year 7.
doi:10.1371/journal.pone.0015977.t001
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At baseline (year 2 of CARDIA, Table 1) the average age of
these study subjects free of diabetes was 27.263.3 years (mean 6
standard deviation). Men and whites were 31.1% and 51.1% of
the sample, respectively. BMI was 29.166.7 kg/m
2 at year 2; and
33.067.9 kg/m
2 at year 20.
Among various OC pesticides,the moststatistically significant year
2 predictor of BMI at year 20, was p,p’-DDE (Table 2).However,an
increase of .6k g / m
2 in mean BMI was observed only up to the 3
rd
quartile of p,p’-DDE, while mean BMI decreased in the 4
th quartile
(Pquadratic,0.01). p,p’-DDT also appeared to predict BMI at year 20,
but the dose-response curve was close to a linear increase
(Ptrend=0.05). The associations between PCBs and BMI differed
depending on PCB congener. For example, PCB170, PCB180, or
PCB206showedthehighestincreaseofBMIinthe2
nd quartile, while
BMI decreased at higher concentrations of these PCBs, making
inverted U-shaped associations. However, PCB156, PCB194, and
PCB209 showed decreasing trendsofBMI fromthe 2
ndto4
th quartile
with little or no increase of BMI from the 1
st to 2
nd quartile.
Plasma triglycerides were 77.9646.4 mg/dL at year 2 and
97.3661.5 mg/dL at year 20. Among OC pesticides, oxychlor-
dane, trans-nonachlor, hexachlorobenzene, and p’p-DDE predict-
ed future triglycerides at year 20 after adjusting for triglycerides at
year 2 (Table 3). Oxychlordane, trans-nonachlor, and p’p-DDE
showed increase in triglycerides in the 2
nd quartile with lower
Table 2. Adjusted* means of body mass index (kg/m
2) at year 20 according to quartiles of organochlorine (OC) pesticides,
polychlorinated biphenyl (PCBs) or polybrominated biphenyl (PBB).
Quartiles of OC pesticides, PCBs, or PBB
Compounds Q1 Q2 Q3 Q4 Ptrend Pquadratic
OC pesticides
Oxychlordane 32.0 35.5 32.2 32.4 0.68 0.17
Trans-nonachlor 31.8 34.5 32.7 33.0 0.79 0.37
Hexachlorobenzene 32.3 32.8 32.0 35.1 0.37 0.33
b-hexachlorocyclohexane 31.4 33.4 33.9 33.2 0.43 0.35
c- hexachlorocyclohexane 32.5 32.7 32.3 34.6 0.34 0.42
p,p’-DDE 29.7 33.1 36.3 32.8 0.05 ,0.01
p,p’-DDT 32.3 30.5 34.0 35.4 0.05 0.21
Mirex 34.0 31.0 34.4 31.6 0.59 0.89
PCBs (number of chlorines)
PCB74 (4) 32.7 32.5 33.8 33.0 0.77 0.79
PCB87 (5) 33.9 32.2 33.5 32.4 0.66 0.82
PCB99 (5) 31.3 33.0 34.0 33.7 0.22 0.46
PCB105 (5) 31.9 34.0 32.6 33.6 0.63 0.74
PCB118 (5) 32.2 33.2 33.7 32.9 0.74 0.51
PCB146 (6) 33.9 34.3 33.0 30.7 0.13 0.33
PCB153 (6) 31.4 35.7 32.9 32.0 0.57 0.07
PCB156 (6) 34.3 35.1 33.0 29.7 0.02 0.13
PCB157 (6) 33.1 35.8 31.7 31.7 0.15 0.38
PCB138–158 (6) 31.4 35.3 31.3 34.0 0.82 0.71
PCB167 (6) 31.8 34.6 32.4 33.2 0.80 0.45
PCB170 (7) 32.5 35.3 33.5 30.6 0.19 0.04
PCB178 (7) 32.7 36.4 32.0 30.8 0.12 0.08
PCB180 (7) 32.8 36.7 32.1 30.3 0.06 0.03
PCB183 (7) 32.2 34.6 33.1 32.1 0.83 0.20
PCB187 (7) 32.6 36.8 31.6 30.9 0.10 0.09
PCB194 (8) 34.6 35.9 32.2 29.2 0.01 0.11
PCB195 (8) 32.5 35.5 33.0 31.0 0.22 0.08
PCB199 (8) 33.5 35.2 33.1 30.0 0.08 0.06
PCB196–203 (8) 33.4 36.1 32.6 29.8 0.05 0.05
PCB206 (9) 33.6 35.0 34.2 29.6 0.09 0.02
PCB209 (10) 34.3 34.6 33.0 30.1 0.05 0.24
PBB
PBB153 34.6 32.4 34.1 30.9 0.15 0.69
*Adjusted for age, sex, race, BMI, triglyceride and total cholesterol at year 2.
doi:10.1371/journal.pone.0015977.t002
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predicted triglycerides with a positive linear trend. Many PCBs
among those with 7 or more chlorides showed statistically
significant low dose effects, having inverted U shaped associations.
Opposite to findings concerning highly chlorinated PCBs, PCB74
(with 4 chlorides) showed a U-shaped association.
Plasma HDL-cholesterol was 53.2613.7 mg/dL at year 2 and
54.1614.5 mg/dL at year 20. The only OC pesticide which
significantly predicted HDL-cholesterol at year 20 was p,p’-DDE
(Table 4). The decrease of HDL-cholesterol was already
evident in the 2
nd quartile, with no further decrease in the 3
rd and
4
th quartiles of p,p’-DDE. All PCBs that had statistically significant
associationswithHDL-cholesterolshowedlow doseeffects.However,
unlike the findings with p,p’-DDE, after the initial decrease of HDL-
cholesterol from the 1
st to 2
nd quartile,
HDL-cholesterol increased from the 2
nd to 4
thquartile of these PCBs.
HOMA-IR increased over 20 years from 2.661.4 to
3.461.9 mmol/L * mIU/mL. p,p’-DDE also predicted HOMA-
IR at year 20 (Table 5). Insulin resistance increased by the 3
rd
quartile of p,p-DDE and did not further increase at higher p,p;-
DDE concentrations. PCBs with 5 chlorides such as PCB87 and
PCB99 linearly predicted HOMA-IR while PCBs with 7 or 8
chlorides showed inverted U-shaped associations.
Calculated LDL-cholesterol was associated with only 3 POPs
(hexachlorobenzene, PBB153, and PCB199) with slightly different
dose-response curves (Table S3).
Table 3. Adjusted* means of triglycerides (mg/dL) at year 20 according to quartiles of organochlorine (OC) pesticides,
polychlorinated biphenyl (PCB) or polybrominated biphenyl (PBB).
Quartiles of OC pesticides, PCBs, or PBB
Compounds Q1 Q2 Q3 Q4 Ptrend Pquadratic
OC pesticides
Oxychlordane 68.3 94.6 89.5 89.3 0.17 0.04
Trans-nonachlor 71.4 93.1 91.8 84.6 0.28 0.04
Hexachlorobenzene 72.5 85.9 80.4 104.1 0.05 0.55
b-hexachlorocyclohexane 80.9 90.3 85.8 82.7 0.97 0.40
c- hexachlorocyclohexane 78.8 95.4 80.8 85.4 0.95 0.46
p,p’-DDE 65.5 92.5 100.5 84.4 0.03 ,0.01
p,p’-DDT 77.4 83.9 87.3 91.7 0.19 0.86
Mirex 85.8 90.4 83.0 82.0 0.65 0.76
PCBs (number of chlorine)
PCB74 (4) 88.6 73.9 82.9 96.5 0.33 0.06
PCB87 (5) 82.7 76.0 97.5 83.9 0.42 0.70
PCB99 (5) 75.4 86.4 88.4 90.0 0.21 0.48
PCB105 (5) 80.8 85.8 91.3 82.1 0.75 0.33
PCB118 (5) 76.9 95.1 80.1 88.5 0.66 0.49
PCB146 (6) 78.1 86.9 91.9 82.8 0.70 0.23
PCB153 (6) 77.3 84.1 92.5 86.2 0.48 0.38
PCB156 (6) 84.0 89.4 82.8 83.7 0.73 0.78
PCB157 (6) 76.7 93.4 78.7 93.8 0.53 0.96
PCB138–158 (6) 73.3 88.5 85.2 93.8 0.15 0.60
PCB167 (6) 74.3 89.5 85.4 91.3 0.22 0.49
PCB170 (7) 77.5 87.6 88.2 86.6 0.63 0.42
PCB178 (7) 76.7 92.3 91.3 79.8 0.96 0.06
PCB180 (7) 78.2 89.8 85.8 86.0 0.76 0.43
PCB183 (7) 70.8 90.1 95.6 84.6 0.17 0.03
PCB187 (7) 74.8 91.9 94.3 79.5 0.90 0.03
PCB194 (8) 75.1 99.1 79.9 87.0 0.90 0.31
PCB195 (8) 77.2 95.0 87.6 80.7 0.88 0.11
PCB199 (8) 76.8 93.4 93.2 77.1 0.89 0.02
PCB196–203 (8) 75.5 95.1 86.2 83.5 0.87 0.14
PCB206 (9) 77.6 92.1 91.3 79.1 0.95 0.06
PCB209 (10) 86.0 97.6 84.3 73.5 0.18 0.12
PBB
PBB153 84.8 80.0 100.1 76.3 0.69 0.22
*Adjusted for age, sex, race, BMI, triglyceride and total cholesterol at year 2.
doi:10.1371/journal.pone.0015977.t003
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and PCB178 in Figure 1 and Figure 2; these POPs predicted
most metabolic profiles and pictorialize some of the kinds of dose-
response curves reported in the tables. We also displayed the
consistency across several POPs associations that were significant
or marginally significant (ptrend or pquadratic,0.1) in Tables 1, 2,
3, 4 and in Figure S1 and Figure S2.
Discussion
In this prospective study, some OC pesticides and PCBs
predicted excess adiposity, dyslipidemia, and insulin resistance
among participants without diabetes. Similar to observed risk for
type 2 diabetes[1], low dose OC pesticides and PCBs showed
strong associations, often with inverted U-shaped associations.
The past two decades have observed an explosive worldwide
increase in the number of type 2 diabetic patients,with obesity
regarded as a primary cause. Metabolic changes precede the
development of type 2 diabetes by years or even decades. Insulin
resistance is regarded as the initial metabolic defect, and dyslipidemia
is also commonly observed. At first, the pancreatic beta-cells are able
to compensate by increasing insulin secretion, but, as insulin
resistance worsens, type 2 diabetes occurs when the pancreas fails
to sustain this compensatory activity. Our study showed that POPs
are likely involved in all these steps of pathogenesis of type 2 diabetes,
even including the development of obesity. Importantly, different
Table 4. Adjusted* means of HDL-cholesterol (mg/dL) at year 20 according to quartiles of organochlorine (OC) pesticides,
polychlorinated biphenyl (PCB) or polybrominated biphenyl (PBB).
Quartiles of OC pesticides, PCBs, or PBB
Compounds Q1 Q2 Q3 Q4 Ptrend Pquadratic
OC pesticides
Oxychlordane 52.6 51.8 54.6 50.7 0.85 0.57
Trans-nonachlor 55.2 49.9 52.9 51.9 0.55 0.32
Hexachlorobenzene 52.6 51.6 54.3 51.2 0.98 0.64
b-hexachlorocyclohexane 55.7 48.3 54.8 51.4 0.72 0.37
c- hexachlorocyclohexane 53.6 52.8 54.1 49.4 0.27 0.34
p,p’-DDE 61.5 49.9 49.7 49.6 ,0.01 0.01
p,p’-DDT 53.1 52.7 54.5 49.6 0.41 0.32
Mirex 52.0 57.0 49.3 53.2 0.72 0.93
PCBs (number of chlorines)
PCB74 (4) 50.2 55.5 51.8 52.3 0.91 0.33
PCB87 (5) 53.9 53.9 50.1 52.1 0.36 0.66
PCB99 (5) 53.1 55.7 50.8 50.1 0.19 0.47
PCB105 (5) 51.5 51.7 54.6 51.9 0.65 0.52
PCB118 (5) 49.7 55.1 52.3 52.8 0.65 0.26
PCB146 (6) 51.5 48.9 54.1 55.4 0.16 0.41
PCB153 (6) 56.0 47.7 52.8 53.8 0.68 0.05
PCB156 (6) 52.0 49.1 51.5 57.3 0.09 0.06
PCB157 (6) 53.9 48.3 51.5 56.1 0.26 0.03
PCB138–158 (6) 53.8 50.0 54.4 51.8 0.94 0.79
PCB167 (6) 52.7 50.9 53.9 52.3 0.87 0.96
PCB170 (7) 53.4 49.4 49.4 58.2 0.15 ,0.01
PCB178 (7) 53.9 46.5 53.4 57.0 0.11 0.02
PCB180 (7) 52.7 47.9 51.3 58.7 0.05 ,0.01
PCB183 (7) 52.1 51.2 52.8 53.8 0.61 0.67
PCB187 (7) 55.0 45.0 55.1 55.9 0.14 0.02
PCB194 (8) 50.5 48.1 51.9 60.1 0.01 0.02
PCB195 (8) 54.0 46.9 51.7 58.1 0.09 ,0.01
PCB199 (8) 52.3 47.3 50.8 61.0 0.02 ,0.01
PCB196–203 (8) 52.3 48.5 52.1 57.6 0.11 0.04
PCB206 (9) 53.6 47.5 49.1 59.7 0.12 ,0.01
PCB209 (10) 53.9 48.7 52.2 55.1 0.54 0.08
PBB
PBB153 55.3 49.7 52.2 52.8 0.74 0.15
*Adjusted for age, sex, race, BMI, triglyceride, total cholesterol, and HDL-cholesterol at year 2.
doi:10.1371/journal.pone.0015977.t004
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metabolic dysregulation. For example, p,p’-DDE predicted increased
BMI, increased triglycerides, decreased HDL-cholesterol, and
increased HOMA-IR in this study, while p,p’-DDE did not predict
type 2 diabetes in the previous study[1]. On the other hand, trans-
nonachlor was most strongly associated with the development of
diabetes, but not BMI, HDL-cholesterol, and HOMA-IR although
trans-nonachlor predicted triglycerides. Therefore, p,p’-DDE may be
influential in development of prediabetic conditions, while trans-
nonachlor may be more important in the progression from insulin
resistance to type 2 diabetes.
An important finding in this study was that some POPs
predicted future BMI. Although imbalance between energy intake
and expenditure is the central mechanism leading to obesity, the
recent surge of obesity might have other causes besides overeating
and physical inactivity. In addition to POPs[11], several selected
environmental pollutants such as diethylstilbesterol, bisphenol A,
phthalate, or tributyltin that cause perturbations in endogenous
hormonal regulation involved in weight homeostasis have been
recently studied as possible risk factors for obesity[16], [17], [18]
although most studies have been performed in animals, focusing
on the fetal exposure to chemicals. Chemicals may cause obesity
by altering homeostatic metabolic set-points, disrupting appetite
controls, perturbing lipid homeostasis to promote adipocyte
hypertrophy, or stimulating adipogenic pathways that enhance
adipocyte hyperplasia during development or in adults[16], [17].
Table 5. Adjusted* means of HOMA-IR (mIU/mL * mmol/L/22.5) at year 20 according to quartiles of organochlorine (OC) pesticides,
polychlorinated biphenyl (PCB) or polybrominated biphenyl (PBB).
Quartiles of OC pesticides, PCBs, or PBB
Compounds Q1 Q2 Q3 Q4 Ptrend Pquadratic
OC pesticides
Oxychlordane 3.0 3.6 2.6 3.0 0.55 0.65
Trans-nonachlor 2.6 3.9 2.7 3.2 0.72 0.34
Hexachlorobenzene 3.4 2.7 2.9 3.3 0.85 0.12
b-hexachlorocyclohexane 2.7 3.2 2.9 3.5 0.23 0.96
c- hexachlorocyclohexane 2.7 3.4 2.9 3.3 0.46 0.66
p,p’-DDE 2.3 3.1 3.6 3.3 0.02 0.06
p,p’-DDT 2.9 2.7 3.2 3.4 0.25 0.67
Mirex 3.0 3.3 3.1 2.9 0.85 0.51
PCBs (number of chlorine)
PCB74 (4) 2.9 2.6 3.3 3.5 0.17 0.55
PCB87 (5) 2.8 2.6 3.3 3.6 0.08 0.42
PCB99 (5) 2.5 2.7 3.4 3.7 0.01 0.90
PCB105 (5) 2.8 2.8 3.1 3.5 0.19 0.68
PCB118 (5) 2.8 2.8 2.8 3.8 0.08 0.19
PCB146 (6) 3.2 3.0 3.0 3.1 0.91 0.71
PCB153 (6) 2.6 3.5 2.8 3.2 0.69 0.52
PCB156 (6) 3.2 3.4 2.8 2.8 0.25 0.78
PCB157 (6) 3.0 3.6 2.5 3.2 0.61 0.66
PCB138–158 (6) 2.7 3.0 2.7 3.8 0.13 0.22
PCB167 (6) 2.7 3.2 2.7 3.7 0.19 0.48
PCB170 (7) 2.7 3.5 3.1 2.8 0.63 0.13
PCB178 (7) 2.8 3.8 3.0 2.6 0.34 0.04
PCB180 (7) 2.8 3.7 2.9 2.8 0.41 0.13
PCB183 (7) 2.8 3.1 3.0 3.3 0.39 0.98
PCB187 (7) 2.8 3.8 2.9 2.8 0.54 0.17
PCB194 (8) 3.0 4.1 2.6 2.5 0.07 0.16
PCB195 (8) 2.9 3.8 3.0 2.6 0.27 0.11
PCB199 (8) 3.1 3.7 3.1 2.4 0.12 0.06
PCB196–203 (8) 2.9 3.9 3.0 2.5 0.16 0.03
PCB206 (9) 3.4 3.7 2.7 2.6 0.10 0.62
PCB209 (10) 3.4 3.4 2.7 2.7 0.18 0.99
PBB
PBB153 3.4 3.1 3.1 2.6 0.17 0.72
*Adjusted for age, sex, race, BMI, triglyceride, and total cholesterol at year 2, and HOMA-IR at year 7.
doi:10.1371/journal.pone.0015977.t005
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PLoS ONE | www.plosone.org 6 January 2011 | Volume 6 | Issue 1 | e15977This study showed that low dose exposure of adults to p,p’-DDE,
p,p’-DDT, and some PCBs with 7 or more chlorines predicted
future BMI. In fact, earlier animal experiments consistently
observed that many chemicals cause weight loss at high exposure,
but much lower concentrations of these same chemicals are
weight-promoting[19].
Figure 1. Effects of p,p’-DDE on BMI, dyslipidemia, and insulin resistance. Adjusted means of year 20 BMI, triglycerides, HDL-cholesterol,
and HOMA-IR according to serum concentrations of p,p’-DDE at year 2. Adjusting variables were age, sex, race, BMI, triglycerides, and total cholesterol
at year 2. Year 20 HDL-cholesterol and HOMA-IR were additionally adjusted for their baseline values at year 2 and year 7, respectively.
doi:10.1371/journal.pone.0015977.g001
Figure 2. Effects of PCB178 on BMI, dyslipidemia, and insulin resistance. Adjusted means of year 20 BMI, triglycerides, HDL-cholesterol, and
HOMA-IR according to serum concentrations of PCB178 at year 2. Adjusting variables were age, sex, race, BMI, triglycerides, and total cholesterol at
year 2. Year 20 HDL-cholesterol and HOMA-IR were additionally adjusted for their baseline values at year 2 and year 7, respectively.
doi:10.1371/journal.pone.0015977.g002
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PLoS ONE | www.plosone.org 7 January 2011 | Volume 6 | Issue 1 | e15977Among the 31 POPs we studied, 10 POPs statistically
significantly or marginally significantly predicted future higher
triglycerides and 14 POPs predicted lower HDL-cholesterol.
However, higher LDL-cholesterol was associated with only 3
compounds. Lipid disorders are common in type 2 diabetes and
play a crucial role in the development of diabetic cardiovascular
complications. In fact, high triglycerides and low HDL-cholesterol,
often with normal LDL-cholesterol, are fundamental characteris-
tics of the metabolic syndrome [20].
Despite the general occurrence in these findings of inverted U-
shaped associations, some dose-response curves followed a
different pattern, depending on outcome and/or specific POP.
Among OC pesticides, hexachlorobenzene predicted future
triglycerides and LDL-cholesterol linearly, while p,p-DDE,
oxychlordane, and trans-nonachlor showed low dose effects.
Dose-response curves also differed between moderately chlorinat-
ed and highly chlorinated PCBs. In the case of moderately
chlorinated PCBs such as PCB87, PCB99, and PCB118, the
evolution of HOMA-IR occurred above the 3
rd quartile. However,
in the case of highly chlorinated PCBs, such as PCB178, PCB194,
and PCB199, mean HOMA-IR increased from the 1
st to 2
nd
quartile and then clearly decreased through the 4
th quartile,
forming inverted U-shaped associations.
Similar to the associations between low dose POPs and type 2
diabetes, underlying mechanisms for associations between POPs
and disturbances in glucose and lipid metabolism have been little
studied. As PCB congeners with affinity to Aryl hydrocarbon
receptor (AhR), like PCB105, PCB118, and PCB167, were not
associated with any outcome in this study, affinity to AhR may not
play an important mechanistic role in the metabolic disturbances
studied here. Also, estrogenic activity is unlikely to be critical
because both estrogenic PCB187 and antiestrogenic PCB170
showed similar associations. In addition, although p,p-DDT has a
weak-estrogenic activity, p,p’-DDE, the OC pesticide which was
strongly associated with most outcomes in this study and the most
persistent metabolite of commercial DDT, is an anti-androgen
rather being a weak estrogen[21]. The only common property of
PCB groups which predicted BMI, dyslipidemia, or HOMA-IR
appeared to be their long persistency because the persistence of
PCB congeners increases with the number of chlorines[22].
The findings on POPs observed in both current and previous
studies may help to explain the current world-wide epidemic of
metabolic syndrome and type 2 diabetes. The disturbances of
glucose and lipid metabolism due to POPs seem to require at least
two conditions; low dose and persistency. As serum concentrations
of most chlorinated POPs have decreased during several decades,
low doses of POPs among our study subjects which were measured
in stored serums in 1987 to 1988 were similar to the highest
concentrations currently seen in the general population. A very
long exposure to POPs may be another critical condition. Because
POPs have been released into the environment since the 1950s, we
can assume that our study subjects had lifetime exposure to these
chemicals. Therefore, in terms of both exposure dose and
duration, the current general population may be at higher risk
of developing glucose and lipid dysmetabolism due to POPs than
were earlier general populations. In addition, obesity appeared to
worsen the problem, because the associations between individual
POPs and type 2 diabetes were observed only among obese
persons in our previous study. Also, the exposure to xenobiotics
such as POPs may contribute to the development of obesity.
Finally, findings observed in man may be explained by the effects
of individual POPs working together. Combinations of endocrine
disrupting chemicals are able to produce significant effects, even
when each chemical is present at low doses that individually do not
induce observable effects[23]. As the general population is
simultaneously exposed to a mixture of several hundred POPs, a
cocktail effect due to mixed POPs may be important.
A limitation of this study is potentially false positive associations
among the many associations evaluated. We assessed the possible
effect of multiple testing under a binomial model by counting the
number of significant findings (p,0.05) among the 62 linear or
quadratic tests performed for each outcome, compared to 3.1 tests
(95% confidence interval 0 to 6.5) expected to achieve p,0.05 under
thenullhypothesis.As11testswithBMI,7testswithtriglyceride,and
15 tests with HDL-cholesterol achieved statistical significance, many
of the associations of POPs with BMI, triglyceride, and HDL-
cholesterol observed in the current study were unlikely under the null
hypothesis, even considering multiple testing. As only 3 of 62 tests
concerning LDL-cholesterol achieved statistical significance, multiple
testing might well explain these apparently significant tests. The
situation concerning evaluation of HOMA-IR is more complex.
Although only 4 of 62 tests achieved statistical significance, the range
of HOMA-IR was constrained by excluding anyone with impaired
fastingglucoseover20years.Thisexclusionrestrictsglucoseexplicitly
and insulin secondarily. Furthermore, the significant associations that
were observed were with p,p’-DDE and PCB178, both consistently
showed significant associations with BMI, triglycerides, and HDL-
cholesterol. Metabolic syndrome links BMI, triglycerides, and HDL-
cholesterol with HOMA-IR, so that it is physiologically reasonable to
expect similar associations of POPs with each of these variables.
Therefore, the findings concerning p,p’-DDE and PCB178 with
HOMA-IR should not simply be dismissed due to multiple testing.
Furthermore, great consistency in prediction was observed for highly
chlorinated PCBs. Another study limitation was small sample size,
which was a compromise related to practicalities of cost and use of
precious samples. Volumes of the available blood samples also
prevented us from measuring dioxins and furans. The primary
strength of the study is the long termfollowup, with baseline measures
of all outcome variables.
In conclusion, low dose POPsmay be involved in the development
of obesity, dyslipidemia, and insulin resistance, although different
POPs may relate to different metabolic traits. As the general
population is simultaneously exposed to various POPs through food
consumption, our findings concerning POPs could help to explain
why these metabolic abnormalities tend to occur as a cluster.
Together with the findings on type 2 diabetes in our previous
report[1], the background exposure to POPs may help to explain the
recent epidemic of obesity, metabolic syndrome, and diabetes.
Supporting Information
Figure S1 Means of year 20 BMI, triglyceride, HDL-cholesterol,
and HOMA-IR according to quartiles of selected organochlorine
pesticides which showed Ptrend,0.1 or Pquadratic,0.1 in
Tables 1, 2, 3, 4 and 5. Adjusted for age, sex, race, BMI,
triglycerides, and total cholesterol at year 2. Year 20 HDL-
cholesterol and HOMA-IR were additionally adjusted for their
baseline values at year 2 and year 7, respectively.
(PDF)
Figure S2 Means of year 20 BMI, triglyceride, HDL-cholesterol,
and HOMA-IR according to quartiles of selected PCBs which
showed Ptrend,0.1 or Pquadratic,0.1 in the Tables 1 to 5.
Adjusted for age, sex, race, BMI, triglycerides, and total
cholesterol at year 2. Year 20 HDL-cholesterol and HOMA-IR
were additionally adjusted for their baseline values at year 2 and
year 7, respectively.
(PDF)
POPs, Obesity, and Obesity-Related Dysmetabolism
PLoS ONE | www.plosone.org 8 January 2011 | Volume 6 | Issue 1 | e15977Table S1 Target analytes with detection rate and abbreviations
used.
(DOCX)
Table S2 Number of subjects in each quartile of organochlorine
(OC) pesticides, polychlorinated biphenyl (PCB) or polybromi-
nated biphenyl (PBB).
(DOCX)
Table S3 Adjusted* means of LDL-cholesterol (mg/dL) at year
20 according to quartiles of organochlorine (OC) pesticides,
polychlorinated biphenyl (PCB) or polybrominated biphenyl
(PBB).
(DOCX)
Author Contributions
Conceived and designed the experiments: DHL MWS DRJ. Performed the
experiments: AS RSJ LLN. Analyzed the data: DHL DRJ. Contributed
reagents/materials/analysis tools: AS RSJ LLN. Wrote the paper: DHL
MWS DRJ.
References
1. Lee DH, Steffes MW, Sjo ¨din A, Jones RS, Needham LL, et al. (2010) Low dose
persistent organic pollutants predict type 2 diabetes: A nested case-control study.
Environ Health Perspect.
2. Lee DH, Lee IK, Steffes M, Jacobs DR, Jr. (2007) Extended analyses of the
association between serum concentrations of persistent organic pollutants and
diabetes. Diabetes Care 30: 1596–1598.
3. Lee DH, Lee IK, Song K, Steffes M, Toscano W, et al. (2006) A strong dose-
response relation between serum concentrations of persistent organic pollutants
and diabetes: results from the National Health and Examination Survey 1999-
2002. Diabetes Care 29: 1638–1644.
4. Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM, et al. (2003)
Large effects from small exposures. I. Mechanisms for endocrine-disrupting
chemicals with estrogenic activity. Environ Health Perspect 111: 994–1006.
5. Daston GP, Cook JC, Kavlock RJ (2003) Uncertainties for endocrine disrupters:
our view on progress. Toxicol Sci 74: 245–252.
6. Turyk M, Anderson H, Knobeloch L, Imm P, Persky V (2009) Organochlorine
exposure and incidence of diabetes in a cohort of Great Lakes sport fish
consumers. Environ Health Perspect 117: 1076–1082.
7. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to
insulin resistance and type 2 diabetes. Nature 444: 840–846.
8. Lee DH, Lee IK, Jin SH, Steffes M, Jacobs DR, Jr. (2007) Association between
serum concentrations of persistent organic pollutants and insulin resistance
among nondiabetic adults: results from the National Health and Nutrition
Examination Survey 1999-2002. Diabetes Care 30: 622–628.
9. Lee DH, Lee IK, Porta M, Steffes M, Jacobs DR, Jr. (2007) Relationship
between serum concentrations of persistent organic pollutants and the
prevalence of metabolic syndrome among non-diabetic adults: results from the
National Health and Nutrition Examination Survey 1999-2002. Diabetologia
50: 1841–1851.
10. Karmaus W, Osuch JR, Eneli I, Mudd LM, Zhang J, et al. (2009) Maternal
levels of dichlorodiphenyl-dichloroethylene (DDE) may increase weight and
body mass index in adult female offspring. Occup Environ Med 66: 143–149.
11. Ruzzin J, Petersen R, Meugnier E, Madsen L, Lock EJ, et al. (2010) Persistent
organic pollutant exposure leads to insulin resistance syndrome. Environ Health
Perspect 118: 465–471.
12. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, et al. (1988)
CARDIA: study design, recruitment, and some characteristics of the examined
subjects. J Clin Epidemiol 41: 1105–1116.
13. Sjodin A, Jones RS, Lapeza CR, Focant JF, McGahee EE, 3rd, et al. (2004)
Semiautomated high-throughput extraction and cleanup method for the
measurement of polybrominated diphenyl ethers, polybrominated biphenyls,
and polychlorinated biphenyls in human serum. Anal Chem 76: 1921–1927.
14. Schisterman EF, Whitcomb BW, Louis GM, Louis TA (2005) Lipid adjustment
in the analysis of environmental contaminants and human health risks. Environ
Health Perspect 113: 853–857.
15. Obana H, Hori S, Tanaka R (1987) The effects of "yusho" type PCB on
triglyceride lipase and fatty acid composition. Environ Res 42: 500–508.
16. Newbold RR, Padilla-Banks E, Jefferson WN (2009) Environmental estrogens
and obesity. Mol Cell Endocrinol 304: 84–89.
17. Grun F, Blumberg B (2009) Endocrine disrupters as obesogens. Mol Cell
Endocrinol 304: 19–29.
18. Desvergne B, Feige JN, Casals-Casas C (2009) PPAR-mediated activity of
phthalates: A link to the obesity epidemic? Mol Cell Endocrinol 304: 43–48.
19. Baillie-Hamilton PF (2002) Chemical toxins: a hypothesis to explain the global
obesity epidemic. J Altern Complement Med 8: 185–192.
20. Szapary PO, Rader DJ (2004) The triglyceride-high-density lipoprotein axis: an
important target of therapy? Am Heart J 148: 211–221.
21. Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA, et al. (1995)
Persistent DDT metabolite p,p’-DDE is a potent androgen receptor antagonist.
Nature 375: 581–585.
22. Contreras Lopez MC (2003) Determination of potentially bioaccumulating
complex mixtures of organochlorine compounds in wastewater: a review.
Environ Int 28: 751–759.
23. Kortenkamp A (2007) Ten years of mixing cocktails: a review of combination
effects of endocrine-disrupting chemicals. Environ Health Perspect 115 Suppl 1:
98–105.
POPs, Obesity, and Obesity-Related Dysmetabolism
PLoS ONE | www.plosone.org 9 January 2011 | Volume 6 | Issue 1 | e15977